The Future of Pancreatic Cancer Treatment: It’s Personal A decade ago, the survival rate for pancreatic cancer hovered around five percent. Today, the five-year survival rate is 10 percent. “We’ve moved into the double-digits, but there is clearly an urgent need to find better therapies to treat cancer of the
Saint Luke’s Clinical Trial Shows Improvements in Patients with Common Genetic Heart Condition Saint Luke’s Mid America Heart Institute announced the results of a clinical trial that will impact patient care and improve quality of life for patients suffering from the most common genetic heart condition, called hypertrophic cardiomyopathy (HCM).
New Immunotherapy Approach Wiped Out Tumors in Two Patients with Advanced Lung Cancer, Study Reports
New Immunotherapy Approach Wiped Out Tumors in Two Patients with Advanced Lung Cancer, Study Reports Drugs called immune checkpoint inhibitors have transformed treatment of many types of tumors, but metastatic lung cancer has proven more challenging: While these medications have significantly extended survival for some patients, most still do not
Acoustically Triggered Nanorobotics Hold Promise for Cancer Treatment Many incredible cancer-fighting drugs and treatments have been developed in the past few decades, and on paper, they seem like they hold the cure. Because of the way the human body is designed, however, the drugs have a difficult time actually reaching
Research Shows How T-cells Are Blocked from Fighting Cancer Researchers at Salk Institute have uncovered a key insight about how oxidized fat molecules inhibit T-cells from killing cancer cells. Their recent discovery, which was published in the peer-reviewed journal Immunity, discusses ways to make sure the immune system can effectively
New Alzheimer’s Treatment Targets Identified A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer’s disease, as well as existing drugs that have therapeutic potential against these targets. Read more...
Researchers Receive More than $6 Million to Study Diabetes-Related Cardiovascular Disease Over the past two decades, the number of new diabetes cases has almost tripled in the United States, and 80% of patients with Type 2 diabetes die from cardiovascular disease. Read more...
New Cancer Treatments May be on the Horizon — Thanks to mRNA Vaccines The COVID-19 pandemic brought mRNA vaccines into the limelight. But the technology may also prove to be a powerful weapon against hard-to-treat cancers. Read more...
Death Rates are Declining for Many Common Cancers in the U.S., Report Finds The new report — released by the American Cancer Society, the National Cancer Institute, the Centers for Disease Control and Prevention, and other collaborators — found that between 2014 and 2018, death rates dropped for 11 out
Cell-Based Immunotherapy Shows Promise Against Melanoma An immunotherapy based on supercharging the immune system’s natural killer cells has been effective in treating patients with recurrent leukemia and other difficult to treat blood cancers. Now, researchers at Washington University School of Medicine in St. Louis have shown in preclinical studies conducted